Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
Journal: JCO precision oncology
Published: August 21, 2026
Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions.
Journal: Annals of palliative medicine
Published: April 15, 2026
Re: Andrisha-Jade Inderjeeth, Andrew J Martin, Robert R Zielinski et al. Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304). Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.008.
Journal: European urology oncology
Published: February 18, 2026
Novel Utilization of Circulating Tumor DNA in Primary Dedifferentiated Seminal Vesicle Adenocarcinoma: A Case Report of Molecular Clearance Following Multimodal Therapy.
Journal: Journal of medical cases
Published: October 20, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: July 15, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 03, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 07, 2025
Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy.
Journal: European urology oncology
Published: March 12, 2025
Integrating Prostate Specific Membrane Antigen-PET into Clinical Practice for Prostate Cancer.
Journal: PET clinics
Published: February 09, 2025
Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients.
Journal: The Prostate
Published: September 23, 2024
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 16, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 11, 2024
Last Updated: 09/26/2026